Chapter 11 Pharmacologic modification of materials

Jeffrey A. Hubbell

doi:10.1016/1054-8807(93)90052-4

Chapter 11 Pharmacologic modification of materials

Jeffrey A. Hubbell

Chemical and Biomolecular Engineering

Research output: Contribution to journal › Article › peer-review

Abstract

Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

Original language	English (US)
Pages (from-to)	121-127
Number of pages	7
Journal	Cardiovascular Pathology
Volume	2
Issue number	3 SUPPL.
DOIs	https://doi.org/10.1016/1054-8807(93)90052-4
State	Published - 1993

ASJC Scopus subject areas

Pathology and Forensic Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/1054-8807(93)90052-4

Cite this

@article{2e15d43691274e5ead6ecf483b215f33,

title = "Chapter 11 Pharmacologic modification of materials",

abstract = "Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.",

author = "Hubbell, {Jeffrey A.}",

year = "1993",

doi = "10.1016/1054-8807(93)90052-4",

language = "English (US)",

volume = "2",

pages = "121--127",

journal = "Cardiovascular Pathology",

issn = "1054-8807",

publisher = "Elsevier Inc.",

number = "3 SUPPL.",

}

TY - JOUR

T1 - Chapter 11 Pharmacologic modification of materials

AU - Hubbell, Jeffrey A.

PY - 1993

Y1 - 1993

N2 - Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

AB - Several approaches have been used to develop biomaterials with pharmacologic activity for use in cardiovascular medicine. These approaches depend upon whether the active agent is to be: (i) released slowly from the device; or (ii) retained in bound form indefinitely. The approaches also depend upon whether the pharmacologic activity of the agent is designed to modulate local: (i) coagulation; (ii) platelet function; or (iii) cell function in the vessel.

UR - http://www.scopus.com/inward/record.url?scp=4043074637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043074637&partnerID=8YFLogxK

U2 - 10.1016/1054-8807(93)90052-4

DO - 10.1016/1054-8807(93)90052-4

M3 - Article

AN - SCOPUS:4043074637

SN - 1054-8807

VL - 2

SP - 121

EP - 127

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

IS - 3 SUPPL.

ER -

Chapter 11 Pharmacologic modification of materials

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this